Breast cancer is the most common malignancy and leading death cause of malignancy in women in the world. Expression of estrogen receptors (ER) and progesterone receptors (PR) has long been used to determine endocrine therapy patients. Family of human epidermal growth factor receptor, namely (HER-2/neu) has been used as markers to predict prognosis and therapy response. But many ductal breast carcinoma patients showed expression of ER, PR, and HER-2 neu negative (triple negative tumors). There should be further research for patients with triple negative tumors, to find prognostic markers and therapies. The purposed of this study was to analyze the relationship between hormonal status and HER-2 expression with cyclin D1expression in breast ductal carcinoma. This study was an observational analytic study, conducted at the Department of Pathology Faculty of Medicine Airlangga University/Dr. Soetomo. Paraffin blocks of 35 patients with invasive ductal breast carcinoma, which has not been treated with anti-cancer drug, in a variety hormonal status and HER-2 neu expression, followed by immunohistochemical examination. The results obtained, 31.4% patients in the age group 50 to 59 years. Cyclin D1 positive expression in 54.3% samples, and positive in 87.5% samples with ER positive and negative in 55.6% samples with negative ER. In positive PR sample, cyclin D1 positive in 72.7% samples, and cyclin D1 negative in 54.2% samples with negative PR.. Also showed that cyclin D1 positive in 85.7% samples with HER-2 positive and negative in 66.7% samples with HER-2 negative. In conclusion, there is a positive correlation between expression of ER and HER-2 neu by cyclin D1 expression.
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.